ATE88343T1 - Anxiolytisches praeparat. - Google Patents

Anxiolytisches praeparat.

Info

Publication number
ATE88343T1
ATE88343T1 AT87309984T AT87309984T ATE88343T1 AT E88343 T1 ATE88343 T1 AT E88343T1 AT 87309984 T AT87309984 T AT 87309984T AT 87309984 T AT87309984 T AT 87309984T AT E88343 T1 ATE88343 T1 AT E88343T1
Authority
AT
Austria
Prior art keywords
anxiolytic
preparations
medetomidine
useful
treatment
Prior art date
Application number
AT87309984T
Other languages
English (en)
Inventor
Risto Lammintausta
Raimo Virtanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of ATE88343T1 publication Critical patent/ATE88343T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT87309984T 1986-11-11 1987-11-11 Anxiolytisches praeparat. ATE88343T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI864570A FI864570A0 (fi) 1986-11-11 1986-11-11 Terapeutiskt anvaendbar foerening.
EP87309984A EP0270267B1 (de) 1986-11-11 1987-11-11 Anxiolytisches Präparat

Publications (1)

Publication Number Publication Date
ATE88343T1 true ATE88343T1 (de) 1993-05-15

Family

ID=8523472

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87309984T ATE88343T1 (de) 1986-11-11 1987-11-11 Anxiolytisches praeparat.

Country Status (12)

Country Link
US (1) US4783477A (de)
EP (1) EP0270267B1 (de)
JP (1) JPS63135330A (de)
AT (1) ATE88343T1 (de)
AU (1) AU587144B2 (de)
DE (1) DE3785549T2 (de)
DK (1) DK175040B1 (de)
ES (1) ES2054687T3 (de)
FI (1) FI864570A0 (de)
HU (1) HU201472B (de)
IE (1) IE60121B1 (de)
ZA (1) ZA878055B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
GB9111732D0 (en) 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
GB2256135B (en) 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
PL341009A1 (en) * 1997-12-04 2001-03-12 Allergan Sales Substitute derivatives of imidazole exhibiting agonist-like activity in respect to adrenergic alpha 2b or 2b/2c receptors
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
CA2884926C (en) * 2012-10-15 2021-09-21 Orion Corporation A veterinary method of alleviating noise aversion
CA2924233C (en) 2013-10-07 2018-10-23 Teikoku Pharma Usa, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
KR101948779B1 (ko) 2013-10-07 2019-05-21 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
CA2924236C (en) 2013-10-07 2020-01-07 Teikoku Pharma Usa, Inc. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
BR112019006955A2 (pt) 2016-10-31 2019-07-02 Teikoku Pharma Usa Inc métodos de controle da dor usando dispositivos de distribuição transdérmica de dexmedetomidina
EP3554501B1 (de) * 2016-12-13 2021-06-09 Orion Corporation Dexmedetomidin oder medetomidin zur verwendung bei der behandlung von trennungsangst bei begleittieren

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1560271A (en) * 1977-01-14 1980-02-06 Joullie International Sa Therapeutically useful m-trifluoromethylphenylpiperazine derivatives
US4147872A (en) * 1977-09-13 1979-04-03 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor
ZA815327B (en) * 1980-08-05 1982-07-28 Hoffmann La Roche Benzazepine derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4575510A (en) * 1983-02-17 1986-03-11 Merrell Dow Pharmaceuticals Inc. Method of alleviating withdrawal symptoms
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
NL8500047A (nl) * 1985-01-09 1986-08-01 Philips Nv Televisie ontvanger met teletext-decodeerschakeling en paginanummergeheugen.

Also Published As

Publication number Publication date
ZA878055B (en) 1988-04-26
JPS63135330A (ja) 1988-06-07
EP0270267A2 (de) 1988-06-08
DK496687A (da) 1988-05-12
DK175040B1 (da) 2004-05-10
ES2054687T3 (es) 1994-08-16
DE3785549T2 (de) 1993-09-09
HU201472B (en) 1990-11-28
IE60121B1 (en) 1994-06-01
IE873015L (en) 1988-05-11
AU587144B2 (en) 1989-08-03
EP0270267B1 (de) 1993-04-21
EP0270267A3 (en) 1990-07-04
HUT45399A (en) 1988-07-28
FI864570A0 (fi) 1986-11-11
DK496687D0 (da) 1987-09-22
DE3785549D1 (de) 1993-05-27
US4783477A (en) 1988-11-08
AU7826987A (en) 1988-05-12

Similar Documents

Publication Publication Date Title
ATE88343T1 (de) Anxiolytisches praeparat.
DK130387A (da) Transglutaminase inhibitorer
DE3774918D1 (de) Cancerostatisches mittel.
DE3780618D1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
IT1200852B (it) Procedimento e dispositivo per l'alimentazione di elementida montare
DE3484549D1 (de) (3-amino-1h-pyrazol-4-yl)(aryl)ketone.
FI850781A0 (fi) Foerfarande foer framstaellning av av l-karnitin pao mikrobiologiskt saett.
IT1211197B (it) Pannelli dispositivo per l alimentazione di
DK472688D0 (da) Anvendelse af bezafibrat til behandling af diabetes
ATE92318T1 (de) Isolierung von castanospermin und dessen verwendung als antidiabetisches heilmittel.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
FI873125A0 (fi) Foerfarande foer framstaellning av 5,6-substituerade 2,4-kinazolindiaminer samt nya mellanprodukter.
FI844645A0 (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
GB8616889D0 (en) Source of power
TR24449A (tr) Tiyazinol tuerevleri hazirlanmalarina mahsus usul v ve fungusid olarak kullanimi
NO862454L (no) Fremgangsmaate for behandling av peroxydblekeavluter.
IT8603003V0 (it) Crick martinetto del 2000
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
BG44031A3 (bg) Метод за получаване на цефалоспорини
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
BR6602230U (pt) Chuveiro portatil desmontavel
PL208128A1 (pl) Sposob napedu i ustalania polozen stolow dwustanowiskowych
LV5575A3 (lv) Ziedes iegusanas panemiens psoriazes arstesanai
BG39455A1 (en) Low- frequency transistor amplifier of power

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time